Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finerenone Effect on Progression of Diabetic Retinopathy in FIDELIO-DKD and FIGARO-DKD Participants
2020-003865-20Phase 2Completed
- Sponsor
- Bayer
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic retinopathy (DR) comparing Finerenone arm with Placebo arm (2 arms). Primary endpoint: Progression of non-proliferative diabetic retinopathy. Started Jan 2021; status: completed.
02
Drugs
finerenone
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on 2020-003865-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003865-20.